Form 4: Macrogenics Director David C. Stump Reports Transactions in Company Stock
SEC Form 4 Filing
Director David C. Stump reports acquisition and disposal of Macrogenics Inc. stock and derivative securities.
Summary
- On May 20, 2025, David C. Stump, a director of Macrogenics Inc., reported transactions involving the company's stock.
- He disposed of 11,000 shares of common stock.
- He acquired 6,500 shares of common stock through the vesting of restricted stock units (RSUs).
- On May 21, 2025, he acquired 3,750 RSUs and options to buy 22,000 shares of common stock at $1.49 per share.
- The RSUs vest one year from the grant date or the day before the next annual meeting, if earlier.
- The stock options vest in monthly increments over one year from the grant date and expire on May 21, 2035.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it's a standard disclosure of insider transactions. There's no indication of positive or negative sentiment towards the company's prospects.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors monitor these filings to gain insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 05/20/2025 | Date of common stock disposal and RSU vesting. |
| 05/21/2025 | Date of RSU and stock option acquisition; Macrogenics' 2025 Annual Meeting of Stockholders. |
| 05/21/2035 | Expiration date of the acquired stock options. |
| 05/22/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Macrogenics, MGNX, Director, David C. Stump, Stock Options, Restricted Stock Units, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.